Behrakis

Pop Singer & Songwriter Zoe Behrakis To Release Jaunty New Pop Groove "Echo" September 18

Retrieved on: 
Thursday, September 17, 2020
Albums, Songs, Echo, Zoe, Behrakis

BOSTON, Sept. 17, 2020 /PRNewswire/ --Emerging pop singer and songwriter Zoe Behrakis is back with an impressive new single "Echo," which will be released everywhere digitally on Friday, September 18.

Key Points: 
  • BOSTON, Sept. 17, 2020 /PRNewswire/ --Emerging pop singer and songwriter Zoe Behrakis is back with an impressive new single "Echo," which will be released everywhere digitally on Friday, September 18.
  • The impressive Greek-blooded pop songstress makes a strong return with another melodic and upbeat pop groove with a chill vibe and chorus that can easily get nestled into your subconscious.
  • "It has such an empowering message: accept your anxieties as a part of you, and not be afraid of them," Zoe stated.
  • "She's a tremendous new talent who pop music lovers will be able to relate to!"

AZTherapies Announces Appointment of Pharma Industry Veteran George D. Behrakis to its Board of Directors

Retrieved on: 
Wednesday, August 7, 2019
Health, Companies, Northeastern University, Behrakis, Tylenol, Elmaleh, Johnson & Johnson, Tufts University, Pharmacy, George D. Behrakis

David R. Elmaleh, Ph.D., Founder, CEO, and Chairman of AZTherapies commented on the appointment: We are pleased to welcome George to our Board.

Key Points: 
  • David R. Elmaleh, Ph.D., Founder, CEO, and Chairman of AZTherapies commented on the appointment: We are pleased to welcome George to our Board.
  • A former pharmacist and pharmaceutical innovator, Mr. Behrakis is well known in the industry for his contributions to the successful development and commercial launch of Tylenol while at Johnson & Johnson.
  • Mr. Behrakis is the former Vice Chair of the Board of Northeastern University, and former Board member of Brigham and Womens Hospital and Tufts Medical Center.
  • AZTherapies is increasingly being recognized for its innovative approach to Alzheimers and other neurodegenerative diseases, said Mr. Behrakis.